Primary endpoints

Related by string. primary endpoint * pri mary . PRIMARY . primary : Primary Care Trust . Primary Leaving Examinations . Primary Care Trusts / EndPoint . Endpoints . Endpoint : primary efficacy endpoint . Secondary endpoints include . secondary efficacy endpoints * specified primary endpoint . Meets Primary Endpoint . Meet Primary Endpoint . Achieves Primary Endpoint *

Related by context. Frequent words. (Click for all words.) 78 Secondary endpoints 74 Secondary endpoints include 73 Secondary endpoints included 71 prospectively defined 68 secondary efficacy endpoints 67 achieved statistical significance 67 composite endpoint 67 Thrombolysis 66 erythrocyte sedimentation rate 65 Randomized controlled 65 Negative Syndrome 65 secondary endpoint 65 #mg/day [001] 64 mg BID 64 mg QD 64 apolipoprotein B 64 plus methotrexate 64 estimated glomerular filtration 64 laboratory abnormalities 64 irbesartan 64 prespecified 64 serum uric acid 64 active comparator 64 PREZISTA r 64 μg kg 64 cytogenetic response 64 nonrandomized 64 HbA 1c 63 concomitant medications 63 PANSS 63 mucosal healing 63 Response Evaluation Criteria 63 ADAS cog 63 secondary endpoints 63 Unified Parkinson Disease 63 primary hypercholesterolemia 63 noninferiority 63 pharmacodynamic effects 63 6R BH4 62 clinical endpoints 62 hypoglycemic events 62 myocardial infarction stroke 62 creatinine clearance 62 retinal thickness 62 evaluable 62 primary efficacy endpoints 62 serum phosphorus 62 serum calcium 62 cardiovascular morbidity 62 univariate 62 blinded placebo controlled 62 tolvaptan 62 ascending doses 62 HbA1C 62 patients evaluable 62 serum concentrations 62 glomerular filtration rate 62 Pharmacokinetic 61 HbA1c levels 61 subscales 61 annualized relapse 61 fasting plasma glucose 61 fatal myocardial infarction 61 preoperatively 61 HSCT 61 tumor lysis syndrome 61 pharmacokinetic profiles 61 mcg kg 61 echocardiographic 61 DAS# [002] 61 Pegasys ® 61 Postoperative 61 lymphopenia 61 QTc 61 % CI #.#-#.# [003] 61 efficacy endpoints 61 T2DM 61 olmesartan 61 CI -#.# 61 coronary revascularization 61 cerebrovascular events 61 primary endpoints 61 tolerated dose MTD 61 dose limiting toxicities 61 surrogate endpoint 61 limiting toxicity 61 dose titration 61 ACR# response 61 p = .# [002] 61 lacosamide 61 mg kg dose 61 J Am Coll 61 efficacy endpoint 60 chlorambucil 60 placebo controlled clinical trials 60 MADRS 60 retinal vein occlusion 60 plus prednisone 60 fasting insulin 60 histologic 60 nonsignificant

Back to home page